Manolis Fousteris

Prof. Dr. Manolis Fousteris

Department of Pharmacy, University of Patras, 26504 Patras, Greece

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
ALAntonios S. Letis
Antonios S. Letis
ESEan-Jeong Seo
Ean-Jeong Seo
SNSotiris S. Nikolaropoulos
Sotiris S. Nikolaropoulos
Thomas EfferthThomas Efferth
Thomas Efferth
AGAthanassios Giannis
Athanassios Giannis
MFManolis Fousteris
Manolis Fousteris

1 October 2010 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
MFManolis Fousteris
Manolis Fousteris
USUndine Schubert
Undine Schubert
DRDaniela Roell
Daniela Roell
JRJulia Roediger
Julia Roediger
NBNikolaos Bailis
Nikolaos Bailis
AGAthanassios Giannis
Athanassios Giannis

11 August 2022 in Bioorganic Chemistry
Verified
Journal Article
Closed access
IAIoannis Avgeris
Ioannis Avgeris
DPDimanthi Pliatsika
Dimanthi Pliatsika
SNSotiris S. Nikolaropoulos
Sotiris S. Nikolaropoulos
MFManolis Fousteris
Manolis Fousteris

2 February 2024 in Bioorganic Chemistry
Verified
Journal Article
Closed access
DKDionysios-Panagiotis Kintos
Dionysios-Panagiotis Kintos
KSKonstantinos Salagiannis
Konstantinos Salagiannis
ASAntonis Sgouros
Antonis Sgouros
SNSotiris S. Nikolaropoulos
Sotiris S. Nikolaropoulos
Stavros TopouzisStavros Topouzis
Stavros Topouzis
MFManolis Fousteris
Manolis Fousteris

1 January 2013 in Anti-Cancer Drugs
Verified
Journal Article
Closed access
IPIoanna C. Papaconstantinou
Ioanna C. Papaconstantinou
MFManolis Fousteris
Manolis Fousteris
AKAnna I. Koutsourea
Anna I. Koutsourea
GPGeorgios N. Pairas
Georgios N. Pairas
APAthanasios D. Papageorgiou
Athanasios D. Papageorgiou
SNSotiris S. Nikolaropoulos
Sotiris S. Nikolaropoulos
On the basis of the results of in-silico predictions and in an effort to extend our structure-activity relationship studies, the aromatic nitrogen mustard 2-[4-N,N-bis(2-chloroethyl) amino-phenyl]butanoic acid (2-PHE-BU) was synthesized and conjugated with various steroidal alcohols. The resulting steroidal esters were evaluated for their in-vivo toxicity and antileukemic activity in P388-leukemia-bearing mice. The new derivatives showed significantly reduced toxicity and marginally improved antileukemic activity compared with free 2-PHE-BU. Nevertheless, they did not prove to be superior either to the template steroidal ester used for in-silico predictions or to previously synthesized steroidal esters of aromatic nitrogen mustards. The results obtained indicate that in-silico design predictions may guide the design and synthesis of new bioactive steroidal esters, but further parameters should be considered aiming at the discovery of compounds with optimum activity.

1 July 2005 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
AKAgnes Kapou
Agnes Kapou
MFManolis Fousteris
Manolis Fousteris
SNSotiris S. Nikolaropoulos
Sotiris S. Nikolaropoulos
MZMaria Zervou
Maria Zervou
Simona Golič GrdadolnikSimona Golič Grdadolnik
Simona Golič Grdadolnik
Thomas MavromoustakosThomas Mavromoustakos
Thomas Mavromoustakos